Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVIVE: Combination Therapy for Obesity and Vascular Function
NCT01351753Phase 2Terminated
- Sponsor
- University of Iowa
- Start
- Mar 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin, orlistat, topiramate in obesity, metabolic syndrome, sponsored by University of Iowa. Started Mar 2011; status: terminated.
02
Drugs
metforminorlistattopiramate
03
Conditions
obesitymetabolic syndrome
Beyond the preview
Go deeper on NCT01351753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01351753.